Palabras clave:

adicciones, COVID-19, salud mental


Objetivo. Indagar acerca de la literatura científica emergente a nivel internacional sobre la repercusión de la pandemia por COVID-19 en las adicciones. Metodología. La base de datos Web of Science se utilizó para analizar la literatura científica sobre la pandemia por COVID-19 y la influencia que ésta pueda tener en el ámbito de las adicciones. Resultados. Se identificaron 320 documentos, de los cuales 38 cumplieron los criterios de inclusión. Sobresalieron tres problemáticas: el consumo de tabaco, opioides y alcohol. Según la literatura incipiente, entre los consumidores de opiáceos existe el riesgo de aumento de las sobredosis, así como un empeoramiento del binomio estrés-alcohol y un peor pronóstico de la enfermedad COVID-19 para los fumadores de tabaco. Destaca la preocupación por la disminución de servicios sanitarios focalizados en las adicciones y la salud mental. Conclusiones. La literatura es muy reciente y es necesaria más evidencia científica que arroje luz. Se pone de manifiesto la preocupación por el alcohol, opioides y tabaco, pero se constata la escasez de referencias a adicciones sin sustancia (nuevas tecnologías, juego online) o a los hipnóticos y las benzodiacepinas.


Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Andrea Sixto Costoya, Universitat de València

Becaria Formación Predoctoral

Rut Lucas Domínguez

Profesora Titular

Víctor Agulló Calatayud, Universitat de València

Profesor Titular


Ahmed, M. Z., Ahmed, O., Aibao, Z., Hanbin, S., Siyu, L., & Ahmad, A. (2020). Epidemic of COVID-19 in China and associated Psychological Problems. Asian Journal of Psychiatry, 51, 102092. doi: 10.1016/j.ajp.2020.102092

Alexander, G. C., Stoller, K. B., Haffajee, R. L., & Saloner, B. (2020). An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19. Annals of Internal Medicine, 19–21. doi: 10.7326/M20-1141

Arya, S., & Gupta, R. (2020). COVID-19 outbreak: Challenges for Addiction services in India. Asian Journal of Psychiatry, 51(March), 102086. doi: 10.1016/j.ajp.2020.102086

Bansal, P., Bingemann, T. A., Greenhawt, M., Mosnaim, G., Nanda, A., Oppenheimer, J.,… Shaker, M. (2020). Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist. The Journal of Allergy and Clinical Immunology: In Practice, 8(6), 1781-1790.e3. doi: 10.1016/j.jaip.2020.04.001

Becker, W., & Fiellin, D. (2020). When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis William. Annals of Internal Medicine, 1–3.

Brake, S. J., Barnsley, K., Lu, W., McAlinden, K. D., Eapen, M. S., & Sohal, S. S. (2020). Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). Journal of Clinical Medicine, 9(3), 841. doi: 10.3390/jcm9030841

Comisión Interamericana para el Control del Abuso de Drogas. (2020). Covid-19 y el tratamiento de trastornos por uso de sustancias. Retrieved from

Cai, G., Bossé, Y., Xiao, F., & Kheradmand, F. (2020). Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2. American Journal of Respiratory and Critical Care Medicine, 201(12), 1–11. doi: 10.1164/rccm.202003-0693LE

Carrico, A. W., Horvath, K. J., Grov, C., Moskowitz, J. T., Pahwa, S., Pallikkuth, S., & Hirshfield, S. (2020). Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS and Behavior, (0123456789), 1–4. doi: 10.1007/s10461-020-02854-w

Clay, J. M., & Parker, M. O. (2020). Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet Public Health, 5(5), 30088–8. doi: 10.1016/S2468-2667(20)30088-8

da Silva, A. C. L., Martelli, H., Ferreti, P. R., Kowalskie, L. P., & da Cruz, D. E. (2020). COVID-19, head and neck cancer, and the need of training of health students and practitioners regarding to tobacco control and patient counseling. Oral Oncology, 106. doi: 10.1016/j.oraloncology.2020.104739

Dunlop, A., Lokuge, B., Masters, D., Sequeira, M., Saul, P., Dunlop, G.,… Maher, L. (2020). Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction Journal, 17(26). doi: 10.1186/s12954-020-00370-7

Editorial. (2020). The COVID-19 pandemic and mental health impacts. International Journal of Mental Health Nursing, 29, 315-318. doi: 10.1111/inm.12726

European Monitoring Centre for Drugs and Drug Addiction. (2020). EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers. Retrieved from

García, L., de la Fuente, L., Sáiz, P. A., García, M. P., & Bobes, J. (2020). ¿Se observarán cambios en el consumo de alcohol y tabaco durante el confinamiento por COVID-19? Adicciones, 32(2), 85–89. doi: 10.20882/adicciones.1546

Gurmeet, A., Mds, S., Surgery, M., & Glasgow, M. (2020). Tobacco use and vaping in the COVID-19 era. Head & Neck, 42(6), 1–3. doi: 10.1002/hed.26208

Hefler, M., & Gartner, C. E. (2020). The tobacco industry in the time of COVID-19: time to shut it down? Tobacco Control, 29(3), 245-246. doi: 10.1136/tobaccocontrol-2020-055807

Jenkins, W. D., Bolinski, R., Bresett, J., Ham, B. V., Fletcher, S., Walters, S.,… Ouellet, L. (2020). COVID-19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities. The Journal of Rural Health, (March), 1–3. doi: 10.1111/jrh.12442

Kar, S. K., Arafat, S. M. Y., Sharma, P., Dixit, A., Marthoenis, M., & Kabir, R. (2020). COVID-19 pandemic and addiction: Current problems and future concerns. Asian Journal of Psychiatry, 51. doi: 10.1016/j.ajp.2020.102064

Kaur, J., & Rinkoo, A. V. (2020). Public health perspectives of smokeless tobacco and areca nut use in the COVID-19 era. Nicotine & Tobacco Research, xx(xx) 1–2. doi: 10.1093/ntr/ntaa081

King, D. L., Delfabbro, P. H., Billieux, J., & Potenza, M. N. (2020). Problematic online gaming and the COVID-19 pandemic. Journal of Behavioral Addictions, 9(2), 184-186. doi: 10.1556/2006.2020.00016

Lazcano, E., & Alpuche, C. (2020). Alfabetización en salud pública ante la emergencia de la pandemia por Covid-19. Salud Pública de México, 62(3), 331–340. doi: 10.21149/11408

Lee, S. A. (2020). Coronavirus anxiety scale: A brief mental health screener for COVID-19 related anxiety. Death Studies, 44(7), 393-401. doi: 10.1080/07481187.2020.1748481

Lima, N. N. R., de Souza, R. I., Gomes, P. W., de Sousa, J. L., Lima da Silva, C. G., & Neto, M. L. R. (2020). People experiencing homelessness: Their potential exposure to COVID-19. Psychiatry Research, 288, 1-2. doi: 10.1016/j.psychres.2020.112945

Lippi, G., Henry, B. M., Bovo, C., & Sanchis, F. (2020). Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis, 7(2), 85-90. doi: 10.1515/dx-2020-0041

Liu, J. J., Bao, Y., Huang, X., Shi, J., & Lu, L. (2020). Mental health considerations for children quarantined because of COVID-19. The Lancet Child & Adolescent Health, 4(5), 347-349. doi: 10.1016/s2352-4642(20)30096-1

Marsden, J., Darke, S., Hall, W., Hickman, M., Holmes, J., Humphreys, K.,… West, R. (2020). Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction, 115(6), 1007-1010. doi: 10.1111/add.15080

Olds, J. L., & Kabbani, N. (2020). Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? The FEBS Journal, 1–5. doi: 10.1111/febs.15303

Reece, A. S., & Hulse, G. (2020). America Addresses Two Epidemics – Cannabis and Coronavirus and their Interactions: An Ecological Geospatial Study. Journal: BMJ Open, 1-58. doi: 10.1101/2020.04.17.20069021

Reynolds, J., & Wilkinson, C. (2020). Accessibility of ‘essential’ alcohol in the time of COVID-19: Casting light on the blind spots of licensing? Drug and Alcohol Review, 39(4), 7–10. doi: 10.1111/dar.13076

Russo, P., Bonassi, S., Giacconi, R., Malavolta, M., Tomino, C., & Maggi, F. (2020). Early View COVID-19 and Smoking. Is Nicotine the Hidden Link? European Respiratory Journal. doi: 10.1183/13993003.01116-2020

Sani, G., Janiri, D., Di Nicola, M., Janiri, L., Ferretti, S., & Chieffo, D. (2020). Mental health during and after the COVID-19 emergency in Italy. Psychiatry and Clinical Neurosciences, 74(6), 372-373. doi: 10.1111/pcn.13004

Satre, D. D., Hirschtritt, M. E., Silverberg, M. J., & Sterling, S. A. (2020). Addressing problems with alcohol and other substances among older adults during the COVID-19 pandemic. The American Journal of Geriatric Psychiatry, (28)7, 780-783. doi: 10.1016/j.jagp.2020.04.012

Sexton, M. (2020). Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence. The Journal of Alternative and Complementary Medicine, 26(6), 444-448. doi: 10.1089/acm.2020.0144

Shalbafan, M., & Khademoreza, N. (2020). What we can learn from COVID-19 outbreak in Iran about the importance of alcohol use education. The American Journal of Drug and Alcohol Abuse, 46(3), 1–2. doi: 10.1080/00952990.2020.1753759

The tobacco Atlas. (2020). Countries. Atlanta: American Cáncer Society and Vital Strategies. Retrieved from

Tindle, H. A., Newhouse, P. A., & Freiberg, M. S. (2020). Beyond Smoking Cessation: Investigating Medicinal Nicotine to Prevent and Treat COVID-19. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco, xx(xx), 1–2. doi: 10.1093/ntr/ntaa077

Tsai, J., & Wilson, M. (2020). COVID-19: a potential public health problem for homeless populations. The Lancet Public Health, 5(4), e186–e187. doi: 10.1016/S2468-2667(20)30053-0

United Nations Office on Drugs and Crime. (2020). Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic. Panama: UNODC. Retrieved from

Usher, K., Bhullar, N., & Jackson, D. (2020). Life in the pandemic: Social isolation and mental health. Journal of Clinical Nursing, 29(15-16), 2756-2757. doi: 10.1111/jocn.15290

Vázquez, J., & Redolar-Ripoll, D. (2020). COVID-19 outbreak impact in Spain: A role for tobacco smoking? Tobacco Induced Diseases, 18, 1–2. doi: 10.18332/tid/120005

Vecchio, S., Ramella, R., Drago, A., Carraro, D., Littlewood, R., & Somaini, L. (2020). COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. Psychiatry Research, 289, 113047, 1-2. doi: 10.1016/j.psychres.2020.113047

Volkow, N. D. (2020). Collision of the COVID-19 and Addiction Epidemics. Annals of Internal Medicine, 173(1), 61-62. doi: 10.7326/m20-1212

Wakeman, S. E., Green, T. C., & Rich, J. (n.d.). An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nature Medicine, 26, 819-820. doi: 10.1038/s41591-020-0898-0

Wilson, C. G., Ramage, M., & Fagan, E. B. (2020). A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder. The Journal of Rural Health, 1-3. doi: 10.1111/jrh.12438

Yang, Y., Li, W., Zhang, Q., Zhang, L., Cheung, T., & Xiang, Y. T. (2020). Mental health services for older adults in China during the COVID-19 outbreak. The Lancet Psychiatry, 7(4), e19. doi: 10.1016/S2215-0366(20)30079-1




Cómo citar

Sixto Costoya, A., Lucas Domínguez, R., & Agulló Calatayud, V. (2021). COVID-19 Y SU REPERCUSIÓN EN LAS ADICCIONES. Health and Addictions/Salud Y Drogas, 21(1).




Artículos más leídos del mismo autor/a